“…In the present study we investigated the HEV seroprevalence among adult population in Ahvaz city and found that anti-HEV IgG and IgM seroprevalence were 46.1% and 1.4%, respectively. The result of the current study is considerably higher than that reported among adults in other parts of Iran [ 16 ]: 9.3% in Nahavand [ 25 ], 8.1% in Isfahan [ 17 ], 7.8% in Western Iran [ 26 ], 7.3% in sari [ 27 ], and 7.9–15% in Tehran [ 28 ]; it is also higher than that reported among adult population of some other countries: 3.9% in United Kingdom [ 16 ], 16.8% in Germany [ 29 ], 7.3% in Spain [ 30 ], about 20% in Korea [ 31 ], 23% in Thailand [ 32 ], 39–42% in USA [ 33 ], and 5.9% in Turkey [ 16 ]; however, it is lower than that reported among rural population older than four years in Egypt (51–78%) [ 16 , 34 ], pregnant women in Nile Delta, Egypt (84%) [ 16 , 35 ], general population older than 11 years in central Malaysia (50–67%) [ 16 ], tribes population (50–100%) and adult population (16–77%) in Andaman Islands, India [ 16 ], and homeless children in Cochabamba city, Bolivia (66%) [ 16 ].…”